Clinical Trials Browser

Phase 1/2 × Carcinoma, Hepatocellular × Injections × Clear all

NCT06641453 2024-10-16

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

Phase 1/2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular